University of Idaho
Moscow, Idaho, 83844, United States
NCT Number: NCT05109039
This study will be a 6 week creatine supplementation intervention with performance familiarization and pre and post testing. Participants will report to the human performance laboratory (HPL) for baseline to read and sign an informed consent explaining the procedures and potential risks and benefits of participation. Participants will then complete a physical activity readiness questionnaire (PAR-Q) prior to performing any physical tasks. Participants will also be asked to complete testing below in the order described. Participants will become familiar with the pre/post performance tests, which include isokinetic testing, medicine ball throw, vertical jump, and Wingate testing. Twenty-four hours following visit 1, participants will return to the HPL for visit 2 where they will undergo a second familiarization session for the isokinetic testing and Wingate testing only - these two tests require individuals to provide maximal physical efforts and research suggests that participants should perform multiple familiarization trials before beginning experimental trials. At least 72 hours following visit 2, participants will return to the HPL for visit 3 to perform the baseline performance assessments. Following the baseline assessments, participants will be divided into two supplementation groups: creatine and placebo (maltodextrin). These groups will be randomized and matched based on body mass, hours of dance training per week, meat intake, and menstrual cycle phase. Participants will be asked to consume one of the two supplements daily for 42 consecutive days and maintain their regular dance training and eating behaviors. Participants will report to the HPL daily to receive their supplement between the hours of 12pm and 2pm. Following the last day of supplement consumption, participants will report to the HPL to perform post-testing assessments which will be identical to pre testing.
Looking for future studies?
Notify Me18 year–24 year
Female
Interventional
Not applicable
Moscow, Idaho, 83844, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will consume 0.1g/kg body weight of creatine with 0.1g/kg body weight of maltodextrin for 42 consecutive days
Participants will consume 0.2g/kg body weight of maltodextrin for 42 consecutive days
Time frame: Change from baseline fat mass at 42 days
Dual energy x-ray absorptiometry used to assess fat mass (% and kg)
Time frame: Change from baseline lean mass at 42 days
Dual energy x-ray absorptiometry used to assess lean mass (% and kg)
Time frame: Change from baseline visceral adipose tissue at 42 days
Dual energy x-ray absorptiometry used to assess visceral adipose tissue (cm2)
Time frame: Change from baseline peak muscular strength at 42 days
Cybex isokinetic dynamometry used to assess peak muscular strength (W)
Time frame: Change from baseline peak vertical jump height at 42 days
Cybex isokinetic dynamometry used to assess vertical jump height (in)
Time frame: Change from baseline upper body muscular power at 42 days
Seated medicine ball toss used to assess upper body muscular power (in)
Time frame: Change from baseline muscular lower at 42 days
Wingate anaerobic power test used to assess muscular power (W)
Time frame: Change from baseline depression, anxiety and stress at 42 days
Depression, anxiety and stress scale (from 0, normal to 42, extremely severe) used to assess depression, anxiety and stress
Time frame: Change from baseline cognitive performance at 42 days
NIH Toolbox for the assessment of Neurological and Behavioral Function ipad application to assess fluid cognitive measures including executive function, attention, episodic memory, processing speed, and working memory.
University of Idaho
Other
Effects of Creatine Supplementation on Performance, Body Composition and Mental Health in Female Collegiate Dancers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06883292
Cognition, Creatine
Tampa, Florida, United States
View Trial DetailsNCT06482619
Creatine, Patellar Tendinopathy
Madrid, Spain
View Trial DetailsNCT05981820
Creatine, High Intensity Interval Training
Gölbaşı, Ankara, Turkey (Türkiye)
View Trial DetailsNCT06948149
Behavior, Cognition Disorders
London, Ontario, Canada
View Trial Details